Dr. Thomas M. Rinderknecht chairs Supervisory Board of GANYMED
Dr. Thomas Rinderknecht, attorney at law, is a senior partner in the law firm RKS Rinderknecht Klein & Stadelhofer and has been specialized for many years in pharma and biotech law and matters. He has held functions on the board of directors of successful biotech companies such as Speedel Holding AG, Glycart Biotechnology AG and SkyePharma
Plc. Dr. Alfred Scheidegger is the founding partner and CEO of Nextech Venture, the lead investor in GANYMED. He also chairs the board of directors of The Genetics Company, Inc., Switzerland.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.